May 10 |
Instil Bio reports Q1 results
|
May 10 |
Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
Apr 12 |
Jefferies cuts Instill Bio to hold, cites drug discontinuation
|
Mar 27 |
What Makes Instil Bio (TIL) a New Buy Stock
|
Mar 22 |
Instil Bio Non-GAAP EPS of -$1.26 beats by $2.14
|
Mar 21 |
Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
Jan 18 |
Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why
|
Jan 17 |
Instil Bio hits four-month high on rising volumes
|
Jan 16 |
Instil Bio Announces Strategic Update
|
Dec 5 |
Instil Bio announces effective date of 1-for-20 reverse stock split
|